key: cord-0770217-hn8mshcy
authors: Goacher, Edward; Phillips, Richard; Mowforth, Oliver D.; Yordanov, Stefan; Pereira, Erlick A. C.; Gardner, Adrian; Quraishi, Nasir A.; Bateman, Antony H.; Demetriades, Andreas K.; Ivanov, Marcel; Budu, Alexandru; Dyson, Edward; Wynne-Jones, Guy; Davies, Benjamin M.; Kotter, Mark R. N.
title: Hospitalisation for degenerative cervical myelopathy in England: insights from the National Health Service Hospital Episode Statistics 2012 to 2019
date: 2022-05-05
journal: Acta Neurochir (Wien)
DOI: 10.1007/s00701-022-05219-5
sha: 46f484266cf03a9f28446781f1142be52431ec8c
doc_id: 770217
cord_uid: hn8mshcy

PURPOSE: Degenerative cervical myelopathy (DCM) is the most common cause of adult spinal cord dysfunction worldwide. However, the current incidence of DCM is poorly understood. The Hospital Episode Statistics (HES) database contains details of all secondary care admissions across NHS hospitals in England. This study aimed to use HES data to characterise surgical activity for DCM in England. METHODS: The HES database was interrogated for all cases of DCM between 2012 and 2019. DCM cases were identified from 5 ICD-10 codes. Age-stratified values were collected for ‘Finished Consultant Episodes’ (FCEs), which correspond to a patient’s hospital admission under a lead clinician. Data was analysed to explore current annual activity and longitudinal change. RESULTS: 34,903 FCEs with one or more of the five ICD-10 codes were identified, of which 18,733 (53.6%) were of working age (18–64 years). Mean incidence of DCM was 7.44 per 100,000 (SD ± 0.32). Overall incidence of DCM rose from 6.94 per 100,000 in 2012–2013 to 7.54 per 100,000 in 2018–2019. The highest incidence was seen in 2016–2017 (7.94 per 100,000). The median male number of FCEs per year (2919, IQR: 228) was consistently higher than the median female number of FCEs per year (2216, IQR: 326). The rates of both emergency admissions and planned admissions are rising. CONCLUSIONS: The incidence of hospitalisation for DCM in England is rising. Health care policymakers and providers must recognise the increasing burden of DCM and act to address both early diagnoses and access to treatment in future service provision plans.

Degenerative cervical myelopathy (DCM) is the most common cause of adult spinal cord dysfunction worldwide, estimated to affect 2% of the adult population [6, [10] [11] [12] 29] . DCM is caused when degenerative, arthritic and/or congenital processes stress and injure the spinal cord [14, 24] . This can lead to a range of disabilities, including imbalance and difficulty walking, loss of manual dexterity, sensory loss, bowel or bladder dysfunction, pain and, in extreme circumstances, paralysis [7, 12] .

The current incidence of DCM is poorly understood but estimated to be around 4 per 100,000 population per year globally [28] . Most figures are based on operative incidence as surgical decompression is the mainstay of treatment, recommended for moderate, severe or progressive DCM [6, 10] . Whilst this is likely to be a major underestimate of overall incidence, given not all patients proceed to surgery, and DCM often goes undiagnosed [3, 19, 30, 32] , the operative incidence has not previously been reported for the UK. Reporting this will add value in not only characterising the diagnostic gap, but also in projecting future surgical This article is part of the Topical Collection on Spine degenerative * Benjamin M. Davies bd375@cam.ac.uk

Extended author information available on the last page of the article demand, which is particularly relevant for a condition positively associated with increasing age [9] . Similarly, increased knowledge of the true incidence of DCM will help predict the future economic impacts of the condition. A survey by Myelopathy.org (Charity No. 1178673) of its DCM community found all patients harbour disabilities despite treatment with 36% unable to work and 42% dependent on others for day to day care [5, 27] . Based on cases diagnosed today (7.4/100,000) the cost to UK society has been calculated as £685 m per year, including an average lifetime loss of earnings for those of working age of £0.5 m [4] .

The Hospital Episode Statistics (HES) database contains details of all secondary care admissions, accident and emergency attendances and outpatient appointments across National Health Service (NHS) hospitals in England [23] . It is a 'big data' source from which data can be retrieved and analysed. The role for HES data has already been demonstrated in work analysing outcomes and costs associated with lumbar spinal surgery [33, 34] .

This study aimed to use HES data to characterise DCM surgical activity in England, including current annual activity and longitudinal change.

To establish the prevalence of DCM in England, we analysed the HES (NHS Digital) database from 2012 to 2019. This period reflects baseline practice, before the implications of the COVID-19 pandemic. The HES database compiles a record of every 'episode' during an admission across NHS England. More than one episode may be associated with an individual admission. HES data helps facilitate payment to NHS care providers, resource allocation and future resource planning across NHS England. NHS Digital is the national provider of data and IT systems for health and social care in NHS England [15] .

Wishlist the HES data is made up of several datasets, detailing all admissions, accident and emergency attendances and outpatient appointments at NHS hospitals in England, only the Hospital Admitted Patient Care Activity dataset, provides data stratified by both diagnostic code and age. This dataset is available at: https:// digit al. nhs. uk/ dataand-infor mation/ publi catio ns/ stati stical/ hospi tal-admit tedpatie nt-care-activ ity# about-this-publi cation [22] . Within the dataset, age-stratified values are provided for 'Finished Consultant Episodes' (FCEs), which correspond to a patient's hospital admission under a lead consultant. Data was collected and compiled by one author (RP), as part of a wider report for Myelopathy.org, seeking to develop a burden of illness model in DCM [20, 25] .

DCM cases were identified from 5 ICD-10 codes: M47.1 (Other spondylosis with myelopathy), M50.0 (Cervical disc disorder with myelopathy), M99.3 Osseous stenosis of neural canal), M99.4 (Connective tissue stenosis of neural canal) and M99.5 (Intervertebral disc stenosis of neural canal). These codes were author selected based on their ICD-10 definition being most closely aligned to the definition of DCM.

Graphs were generated from the data using IBM SPSS version 26.0 (IMB Corp., Armonk, NY).

In total, 34,903 FCEs diagnosed with one or more of the five ICD-10 codes were identified from the HES data analysed between 2012 and 2019.

The mean incidence of DCM was 7.44 (SD ± 0.32). Overall incidence of DCM rose from 6.94 per 100,000 in 2012-2013 to 7.54 per 100,000 in 2018-2019 (Table 1) 

The number of male FCEs for DCM was consistently greater than female episodes across the 7-year period examined (Fig. 1) . Median male number of FCEs per year was 2919 (IQR = 228). The median female number of FCEs per year was 2216 (IQR = 326). However, the male to female (M: F) ratio does appear to be decreasing 

The number of patients admitted as an emergency was consistently fewer than the number of planned admissions. The mean proportion of patients admitted as an emergency was 18.9% (SD ± 1.1%). Numbers for both emergency and planned admissions are rising (Fig. 2) .

In 

The mean waiting time for specialist review following referral from primary care for DCM between 2012 and 2019 was 73 days. Mean waiting time has been moderately stable throughout the 7 years between 50 and 90 days.

Mean length of stay (LoS) was 5 days in all years except 2016-2017, when it rose to 7 days. In comparison, median LoS varied between 1 and 3 days, with the highest LoS again seen in 2016-2017. When examined by ICD-10 diagnosis, M47.1 (Other spondylosis with myelopathy), displayed consistently the highest mean LoS between 2012 and 2019. This was closely followed by diagnosis M50.0 (Cervical disc disorder with myelopathy). The lowest mean LoS was seen in the diagnoses M99.3 (Osseous stenosis of neural canal) and M99.4 (Connective tissue stenosis of neural canal).

This is the first study to utilise HES data to examine DCM activity within England. DCM was more common amongst men than women, and hospitalisation more likely through planned than emergency admission. DCM hospitalisation has risen since 2012, although more recently has plateaued. Further, the gender gap may also be closing. Importantly, observed activity falls far below recent estimates of DCM prevalence [29] . From the open access, population level data in HES, it is difficult to establish the exact nature of each hospital episode. However, the mainstay of treatment for DCM is [7, 17] and broader experience, including regional audits, has demonstrated that the management of most patients within the NHS under a primary diagnostic code of DCM, is related to surgery [13, 14] . Our assumption therefore, is this data is mostly related to surgical activity, and this would accord with national figures from other nations [24] . These studies also demonstrate the higher prevalence of DCM amongst men than women [35] .

This study examined 34,903 FCEs across 7 years. During this time, the overall incidence of DCM rose from 6.94 to 7.54 per 100,000 in England. Whilst one might assume this relates to an ageing population for a condition associated with age [7, 24] , it is noteworthy that the cohort was mostly of working age , and the incidence more recently stable. Another assumption why the incidence is rising within this dataset could be the change in international guidelines for surgery and change in surgical attitude with expanding patients' groups currently being offered treatment for DCM. A recent retrospective cohort study of patients at a single tertiary hospital found that prior to publication of the guidelines, only half of DCM patients who met the criteria for surgical decompression received surgery in routine practice. (12) These numbers also remain far smaller than recent best estimates of DCM prevalence (2.7%) (3). Based on an average time lived with disease of 20 years (UK life expectancy 81.2 minus average age of admissions 62.2), a 2.7% prevalence would equate to an expected incidence of 135/100,000 -20-fold greater than observed. Whilst this will incorporate patients who do not require surgery, it remains a significant diagnostic gap.

Taken together these inconsistencies further support the notion that DCM is widely underdiagnosed. Patients who obtain a diagnosis of DCM will face significant delays and often have been misdiagnosed initially [13, 14, 27] . Addressing this delay is a major priority for DCM as the aim of surgery is principally to halt disease and symptom progression. Whilst most patients will experience some improvement following surgery, a longer time period with symptoms before the intervention leads to poorer outcomes [7] . The ratio of emergency to planned admissions was therefore noteworthy, including a small rise in the percentage of emergency admissions from 19 to 20% during the 7-years analysed. Unfortunately, the data granularity is not sufficient enough to assess if these emergency admissions were associated with previous FCEs or longer waiting times.

Prior analysis of UK referral pathways has shown that even from the point of referral from primary care, access to treatment will take over one year, with patients navigating an inconsistent network of professionals and investigations [14] . This is a widespread issue for neurological disease, leading to the release of NICE Clinical Guidance 127; Suspected neurological conditions: recognition and referral [21] . Unfortunately, DCM was not considered within this framework [21] . This data in this paper supports the need to address how individual's access care, particularly as experience from the USA has demonstrated that patients presenting acutely and requiring emergency admission are more likely to require more complex surgery, with an increase LoS, greater post-operative rehabilitation needs and poorer outcomes [1, 2, 8, 16, 31] . Whilst unreported in the UK, this aligns with the experience of the UK authors.

This study had multiple limitations. Firstly, only HES data from 2012 and onwards was included in this study due to prior inconsistencies in data reporting. Whilst this ensured that only higher quality, consistent data was included, it truncated the time frame for which to examine activity trends. Secondly, interrogation of such 'big data' sources can be associated with a reduced level of data granularity and variability in standards between coders and hospitals which may lead to coding error, omitted data and duplications. A higher level of granularity would have allowed a more detailed analysis of emergency admissions and the impact of patient demographics on waiting times and length of stay. However, for the aims of this study -characterising surgical activity for DCM across England -the HES database provides adequate information to address the primary aim. Similarly, the cost implications of the increasing incidence of hospitalisation for DCM was not assessed, therefore commenting on its economic impact is beyond the scope of this study -future studies may wish to examine this. Furthermore, without a specific ICD code, DCM was queried using a number of defined surrogates felt most faithful to the definition of DCM. These have been used elsewhere [18, 26] , albeit outside of England, but the exact coding practice for English hospitals is currently uncertain. It should be noted that such ICD-10 codes are not procedure specific and in practice, may not always be associated with optimal (surgical) management.

Interrogation of 'big data' sources such as the HES database provides useful and substantial data for clinicians and health care providers to better comprehend and characterise the increasing demands of DCM on health care resources. This data has reinforced the challenges around access to care, with a high proportion of emergency admissions and long waiting times. Furthermore, it highlights the large gap between estimated and actual diagnosis, with a potential health inequality amongst the elderly which requires further evaluation. In short, it is imperative that health care policymakers and providers recognise the burden of DCM and act to address both early diagnosis and timely access to treatment in future service provision plans. 

Disclaimer This report is independent research arising from a Clinician Scientist Award, CS-2015-15-023, supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.

The natural history of degenerative cervical myelopathy

Current diagnosis and management of cervical spondylotic myelopathy

Presymptomatic spondylotic cervical myelopathy: an updated predictive model

Establishing the socio-economic impact of degenerative cervical myelopathy (DCM) is fundamental to improving outcomes

Lessons from recruitment to an internet-based survey for degenerative cervical myelopathy: comparison of free and fee-based methods

Current surgical practice for multi-level degenerative cervical myelopathy: findings from an international survey of spinal surgeons

Degenerative cervical myelopathy

Prolonged length of stay after posterior surgery for cervical spondylotic myelopathy in patients over 65years of age

A global perspective on the outcomes of surgical decompression in patients with cervical spondylotic myelopathy: results from the prospective multicenter aospine international study on 479 patients

A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression

Cervical spondylotic myelopathy: current state of the art and future directions

The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic review

Assessment of degenerative cervical myelopathy differs between specialists and may influence time to diagnosis and clinical outcomes

Route to diagnosis of degenerative cervical myelopathy in a UK healthcare system: a retrospective cohort study

Degenerative cervical myelopathy

Surgical management of cervical myelopathy: indications and techniques for laminectomy and fusion

Surgery for degenerative cervical spine disease in Finland

Prevalence and imaging characteristics of nonmyelopathic and myelopathic spondylotic cervical cord compression

Overview | Suspected neurological conditions: recognition and referral | Guidance | NICE

Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis. Spine (Phila Pa

A review of the data availability for developing of a burden of illness model in DCM

National trends in lumbar spine decompression and fusion surgery in Finland

Diagnostic delays lead to greater disability in degenerative cervical myelopathy and represent a health inequality

High incidence of undiagnosed cervical myelopathy in patients with hip fracture compared with controls

The prevalence of asymptomatic and symptomatic spinal cord compression on magnetic resonance imaging: a systematic review and meta-analysis

MRI changes of cervical spine in asymptomatic and symptomatic young adults

A clinical prediction rule for functional outcomes in patients undergoing surgery for degenerative cervical myelopathy: analysis of an international prospective multicenter data set of 757 subjects

Frequency, timing, and predictors of neurological dysfunction in the nonmyelopathic patient with cervical spinal cord compression, canal stenosis, and/or ossification of the posterior longitudinal ligament

Reoperation following lumbar spinal surgery: costs and outcomes in a UK population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study